MGH358 - Cell Line (ID:51141)
| HMS LINCS ID: | 51141 |
| Name: | MGH358 |
| Alternative Names: | |
| LINCS ID: | |
| Alternative ID: | |
| Parent Cell Line: | |
| Reference Source: | Massachusetts General Hospital |
| Organism: | Homo sapiens |
| Organ: | breast |
| Tissue: | |
| Cell Type: | epithelial |
| Details of Cell Type: | |
| Donor Sex: | female |
| Donor Age: | |
| Donor Ethnicity: | |
| Donor Health Status: | |
| Disease: | |
| Details of Disease: | |
| Production Details: | |
| Genetic Modification(s): | none |
| Known Mutations: | BRCA2, PIK3CA |
| Citation Information for Mutations: | |
| Verification Reference Profile: | |
| Growth Properties: | adherent |
| Recommended Culture Conditions: | Cells are cultured in RPMI-1640 supplemented with 10% FBS and 1% penicillin/streptomycin. Protocol: Aspirate spent medium, wash cells once with PBS, trypsinize cells with 0.25% trypsin. Suspend the trypsinized cells in growth media, and transfer to fresh plates or flasks. A cubcultivation ratio of 1:2 to 1:4 recommended. |
| Relevant Citations: | |
| Usage Note: | |
| Comments: | Established at MGH from patient sample |
| Date Publicly Available: | 2020-03-02 |
| Most Recent Update: | 2020-03-02 |
Batch Information for HMSL51141-1:
| HMS LINCS Batch ID: | 51141-1 |
| Provider: | Massachusetts General Hospital |
| Provider Catalog ID: | |
| Provider Batch ID: | |
| Source Information: | |
| Date Received: | |
| HMS QC Outcome: | |
| Transient Modification(s): | |
| Comments: | |
| Date Publicly Available: | 2020-03-02 |
| Most Recent Update: | 2020-03-02 |